Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease

Autor: Anne C. Brisset, Rocco Sugamele, François Saller, Anne Angelillo-Scherrer, Françoise Bono, Linda Kadi, Shozo Izui, J M Herbert, Laurent Burnier, Peter Carmeliet, Marc Schapira, Lucie Clementine Baudino
Jazyk: angličtina
Rok vydání: 2010
Předmět:
Allogeneic transplantation
T-Lymphocytes
medicine.medical_treatment
Lymphocyte
Immunology
Graft vs Host Disease
Hematopoietic stem cell transplantation
Cell Separation
Biology
ddc:616.07
Endothelial Cells/metabolism
Lymphocyte Activation/immunology
Lymphocyte Activation
Biochemistry
Flow cytometry
Mice
Liver/*immunology/pathology
medicine
Animals
Transplantation
Homologous

Graft vs Host Disease/genetics/immunology/*prevention & control
Mice
Knockout

Transplantation
medicine.diagnostic_test
Reverse Transcriptase Polymerase Chain Reaction
T-Lymphocytes/cytology/immunology/metabolism
Hematopoietic Stem Cell Transplantation
Endothelial Cells
Cell Biology
Hematology
Chemotaxis
Leukocyte/genetics/immunology

medicine.disease
Flow Cytometry
Immunohistochemistry
Chemotaxis
Leukocyte

medicine.anatomical_structure
Graft-versus-host disease
Liver
Hematopoietic Stem Cell Transplantation/*adverse effects
Intercellular Signaling Peptides and Proteins
Tumor necrosis factor alpha
Bone marrow
Lymphocyte Culture Test
Mixed

Intercellular Signaling Peptides and Proteins/*deficiency/genetics
Zdroj: Blood, Vol. 115, No 16 (2010) pp. 3390-3397
ISSN: 0006-4971
Popis: Growth arrest-specific gene 6 (Gas6) is expressed in antigen-presenting cells and endothelial cells (ECs) but not in T cells. When wild-type (WT) or Gas6−/− mice received allogeneic non–T cell–depleted bone marrow cells, hepatic graft-versus-host disease (GVHD) was alleviated in Gas6−/− recipients regardless of donor genotype, but not in WT recipients. T-cell infiltration was more prominent and diffuse in WT than in Gas6−/− recipients' liver. When mice received 0.5 × 106 allogeneic T cells with T cell–depleted allogeneic bone marrow, clinical signs indicated that GVHD was less severe in Gas6−/− than in WT recipients, as shown by a significant improvement of the survival and reduced liver GVHD. These data demonstrate that donor cells were not involved in the protection mechanism. In addition, lack of Gas6 in antigen-presenting cells did not affect WT or Gas6−/− T-cell proliferation. We therefore assessed the response of WT or Gas6−/− ECs to tumor necrosis factor-α. Lymphocyte transmigration was less extensive through Gas6−/− than WT ECs and was not accompanied by increases in adhesion molecule levels. Thus, the lack of Gas6 in ECs impaired donor T-cell transmigration into the liver, providing a rationale for considering Gas6 pathway as a potential nonimmunosuppressive target to minimize GVHD in patients receiving allogeneic hematopoietic stem cell transplantation.
Databáze: OpenAIRE